The FDA vote to approve double chin drug

March 10, 2015 4:52 PM

7 0

The FDA vote to approve double chin drug

A Food and Drug Administration panel has voted – unanimously – to recommend approval of a double chin-reducing injectable drug, the The Wall Street Journal reports.

KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) announced today that the U.S. Food and Drug Administration's (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has voted unanimously to support the approval of ATX-101 (deoxycholic acid) injection for improvement in the appearance of moderate t...

Also read: FDA approves Newron's drug as add-on therapy for Parkinson's

Read more

To category page